Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Amos

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
Rheumatology (Oxford, England)|December 7, 2007
Comment on: Failure of anti-TNF therapy in TNF receptor 1-associated periodic syndrome (TRAPS)S Siebert, N Amos, T M Lawson
Annals of the Rheumatic Diseases|August 1, 1988
Complement mediated inhibition of immune precipitation in rheumatoid arthritis: studies on interaction of heat aggregated IgG with IgM rheumatoid factorM M O'Sullivan, N Amos, B D Williams
Clinical and Experimental Immunology|October 1, 1981
The role of carbohydrate in the structure and function of nephritic factorD M Scott, N Amos, S R Bartolotti
Journal of the American Academy of Audiology|May 2, 1998
Effects of pre-existing hearing loss on proposed ANSI S12.13 outcomes for characterizing hearing conservation program effectiveness: follow-up investigationT H Simpson, N Amos, W F Rintelmann
Clinical and Experimental Immunology|May 1, 1977
C3b receptors in glomerular diseaseJ Moran, G Colasanti, N Amos, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|June 17, 2000
The suppression of rat collagen-induced arthritis and inhibition of macrophage derived mediator release by liposomal methotrexate formulationsA Williams, R Goodfellow, N Topley, et al.
Rheumatology (Oxford, England)|March 31, 2006
Adenoviral gene transfer into osteoarthritis synovial cells using the endogenous inhibitor IkappaBalpha reveals that most, but not all, inflammatory and destructive mediators are NFkappaB dependentN Amos, S Lauder, A Evans, et al.
Rheumatology (Oxford, England)|April 4, 2001
Minocycline-induced lupus: clinical features and response to rechallengeT M Lawson, N Amos, D Bulgen, et al.
Rheumatology International|January 1, 1990
Complement-mediated inhibition of immune precipitation in rheumatoid vasculitisM M O'Sullivan, N Amos, A Bedwell, et al.
The Journal of Clinical Investigation|April 1, 1977
Metabolism of the fifth component of complement, and its relation to metabolism of the third component, in patients with complement activationJ G Sissons, J Liebowitch, N Amos, et al.
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Rheumatology (Oxford, England)|December 7, 2007
Comment on: Failure of anti-TNF therapy in TNF receptor 1-associated periodic syndrome (TRAPS)S Siebert, N Amos, T M Lawson
Annals of the Rheumatic Diseases|August 1, 1988
Complement mediated inhibition of immune precipitation in rheumatoid arthritis: studies on interaction of heat aggregated IgG with IgM rheumatoid factorM M O'Sullivan, N Amos, B D Williams
Clinical and Experimental Immunology|October 1, 1981
The role of carbohydrate in the structure and function of nephritic factorD M Scott, N Amos, S R Bartolotti
Journal of the American Academy of Audiology|May 2, 1998
Effects of pre-existing hearing loss on proposed ANSI S12.13 outcomes for characterizing hearing conservation program effectiveness: follow-up investigationT H Simpson, N Amos, W F Rintelmann
Clinical and Experimental Immunology|May 1, 1977
C3b receptors in glomerular diseaseJ Moran, G Colasanti, N Amos, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|June 17, 2000
The suppression of rat collagen-induced arthritis and inhibition of macrophage derived mediator release by liposomal methotrexate formulationsA Williams, R Goodfellow, N Topley, et al.
Rheumatology (Oxford, England)|March 31, 2006
Adenoviral gene transfer into osteoarthritis synovial cells using the endogenous inhibitor IkappaBalpha reveals that most, but not all, inflammatory and destructive mediators are NFkappaB dependentN Amos, S Lauder, A Evans, et al.
Rheumatology (Oxford, England)|April 4, 2001
Minocycline-induced lupus: clinical features and response to rechallengeT M Lawson, N Amos, D Bulgen, et al.
Rheumatology International|January 1, 1990
Complement-mediated inhibition of immune precipitation in rheumatoid vasculitisM M O'Sullivan, N Amos, A Bedwell, et al.
The Journal of Clinical Investigation|April 1, 1977
Metabolism of the fifth component of complement, and its relation to metabolism of the third component, in patients with complement activationJ G Sissons, J Liebowitch, N Amos, et al.
Pageof 7